---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-342384"
form_type: "8-K"
ticker: "DH"
cik: "0001861795"
company_name: "Definitive Healthcare Corp."
filed_at: "2026-08-10T20:10:18+00:00"
generated_at: "2026-08-10T20:11:20.434809+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Definitive Healthcare Q2 revenue down 9% to $55.2M; adjusted profit beats guidance

## Summary
- Q2 2026 revenue $55.2M, down 9% from $60.8M YoY; net loss improved to $(7.5)M from $(9.3)M.
- Adjusted EBITDA $14.6M (26% margin) vs $18.7M (31% margin) in Q2 2025; adjusted net income $7.5M.
- Operating cash flow $11.5M; unlevered free cash flow $11.6M; launched AI platform Turbo.
- Q3 2026 guidance: revenue $54.0-55.0M, adjusted EBITDA $13.5-14.5M; FY26 revenue $220-222M, adj EPS $0.18-0.20.
- Second consecutive quarter of YoY net dollar retention improvement; six-figure win-back deal.

## SEC filing metadata
- accession: 0001193125-26-342384
- form_type: 8-K
- ticker: DH
- cik: 0001861795
- company_name: Definitive Healthcare Corp.
- filed_at: 2026-08-10T20:10:18+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1861795/000119312526342384/0001193125-26-342384-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1861795/000119312526342384/dh-20260810.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-342384
- JSON: https://secwatch.observer/filing/0001193125-26-342384.json
- Plain text: https://secwatch.observer/filing/0001193125-26-342384.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.